Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Jun;41(6):966–975. doi: 10.1038/bjc.1980.175

Immunization against primary, transplanted and spontaneous murine leukaemia using a live Moloney sarcoma virus vaccine.

A M Mayer, M A Basombrio, C D Pasqualini
PMCID: PMC2010361  PMID: 6252923

Abstract

The purpose of this study was to use an immunization protocol with Moloney sarcoma virus (MSV-M) as active immunogen against exogenous and endogenous leukaemia. The s.c. route was chosen since it offered advantages over the i.m. route: the primary sarcomas were smaller, the regression faster, there were fewer recurrences and there was good persistent immunity. Strong protection was obtained against primary leukaemias induced by Friend leukaemia virus (FLV), Moloney leukaemia virus (MLV), Rauscher leukaemia virus (RLV), Precerutti-Law leukaemia virus (PLLV/T2), and H179A leukaemia virus. It was not possible to protect against leukaemia induced by Gross leukaemia virus (GLV). With transplantable leukaemias the results varied: partial protection was observed against H110 leukaemia (induced with human material) and R14 leukaemia (induced by X-irradiation) whilst no protection was obtained against P277 leukaemia (induced by Moloney leukaemia virus). As for spontaneous leukaemias, immunized BALB/c mice showed an increased incidence over the controls, while in F1 (Swiss x AKR) mice the incidence was similar but the latent period was shorter. Furthermore, in long-term observations the MSV-M-immunized mice showed an increased mortaltiy, which could be related to (1) new phenotypic mixtures between MSV-M and leukaemia viruses; (2) reactivation of MSV-M sarcoma-genesis with age, and (3) genotype susceptibility to MSV-M.

Full text

PDF
966

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AXELRAD A. A. CHANGES IN RESISTANCE TO THE PROLIFERATION OF ISOTRANSPLANTED GROSSVIRUS-INDUCED LYMPHOMA CELLS, AS MEASURED WITH A SPLEEN COLONY ASSAY. Nature. 1963 Jul 6;199:80–83. doi: 10.1038/199080a0. [DOI] [PubMed] [Google Scholar]
  2. BARSKI G., YOUN J. K. IMMUNIZATION AGAINST RAUSCHER MOUSE LEUKEMIA WITH TISSUE CULTURE MATERIAL. Science. 1965 Aug 13;149(3685):751–752. doi: 10.1126/science.149.3685.751. [DOI] [PubMed] [Google Scholar]
  3. Basombrío M. A., Mayer A. M., Pasqualini C. D. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis. Cancer Res. 1977 Jun;37(6):1768–1776. [PubMed] [Google Scholar]
  4. Bianco A. R., Glynn J. P., Goldin A. Induction of resistance against the transplantation of leukemias induced by Rauscher virus. Cancer Res. 1966 Aug;26(8):1722–1728. [PubMed] [Google Scholar]
  5. Chieco-Bianchi L., Collavo D., Colombatti A., Biasi G. In vivo interactions between murine leukemia and sarcoma viruses. Bibl Haematol. 1975;(40):613–620. doi: 10.1159/000397582. [DOI] [PubMed] [Google Scholar]
  6. Chieco-Bianchi L., Colombatti A., Collavo D., Sendo F., Aoki T., Fischinger P. J. Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes. J Exp Med. 1974 Nov 1;140(5):1162–1179. doi: 10.1084/jem.140.5.1162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chirigos M. A., Perk K., Turner W., Burka B., Gomez M. Increased oncogenicity of the murine sarcoma virus (Moloney) by co-infection with murine leukemia viruses. Cancer Res. 1968 Jun;28(6):1055–1063. [PubMed] [Google Scholar]
  8. Colombatti A., Collavo D., Biasi G., Chieco-Bianchi L. Genetic control of oncogenesis by murine sarcoma virus Moloney pseudotype. I. Genetics of resistance in AKR mice. Int J Cancer. 1975 Sep 15;16(3):427–434. doi: 10.1002/ijc.2910160309. [DOI] [PubMed] [Google Scholar]
  9. Dosne Pasqualini C., Saal F., Rabasa S. L. Leucemia murina. Medicina (B Aires) 1968 Dec;28(Suppl):116+–116+. [PubMed] [Google Scholar]
  10. FINK M. A., RAUSCHER F. J. IMMUNE REACTIONS TO A MURINE LEUKEMIA VIRUS. I. INDUCTION OF IMMUNITY TO INFECTION WITH VIRUS IN THE NATURAL HOST. J Natl Cancer Inst. 1964 May;32:1075–1082. [PubMed] [Google Scholar]
  11. FRIEND C. Immunological relationships of a filterable agent causing a leukemia in adult mice. I. The neutralization of infectivity by specific antiserum. J Exp Med. 1959 Feb 1;109(2):217–228. doi: 10.1084/jem.109.2.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fefer A., McCoy J. L., Glynn J. P. Antigenicity of a virus-induced murine sarcoma (Moloney). Cancer Res. 1967 May;27(5):962–967. [PubMed] [Google Scholar]
  13. Fefer A., McCoy J. L., Glynn J. P. Neutralization of the oncogenicity of Moloney sarcoma virus and Moloney leukemia virus by anti-Gross serum. Int J Cancer. 1967 Nov 15;2(6):647–650. doi: 10.1002/ijc.2910020626. [DOI] [PubMed] [Google Scholar]
  14. Fefer A., McCoy J. L., Perk K., Glynn J. P. Immunologic, virologic, and pathologic studies of regression of autochthonous Moloney sarcoma virus-induced tumors in mice. Cancer Res. 1968 Aug;28(8):1577–1585. [PubMed] [Google Scholar]
  15. GLYNN J. P., BLANCO A. R., GOLDIN A. STUDIES ON INDUCED RESISTANCE AGAINST ISOTRANSPLANTS OF VIRUS-INDUCED LEUKEMIA. Cancer Res. 1964 Apr;24:502–508. [PubMed] [Google Scholar]
  16. Giuliani F., Soranzo C., Casazza A. M., Di Marco A. Oncogenicità di cellule linfoidi immuni verso il sarcoma murino di Moloney. Tumori. 1973 Jul-Aug;59(4):269–275. doi: 10.1177/030089167305900403. [DOI] [PubMed] [Google Scholar]
  17. Glynn J. P., McCoy J. L., Fefer A. Cross-resistance to the transplantation of syngeneic Friend, Moloney, and Rauscher virus-induced tumors. Cancer Res. 1968 Mar;28(3):434–439. [PubMed] [Google Scholar]
  18. Harvey J. J., East J. The murine sarcoma virus (MSV). Int Rev Exp Pathol. 1971;10:265–360. [PubMed] [Google Scholar]
  19. Huebner R. J., Gilden R. V., Lane W. T., Toni R., Trimmer R. W., Hill P. R. Suppression of murine type-C RNA virogenes by type-specific oncornavirus vaccines: prospects for prevention of cancer. Proc Natl Acad Sci U S A. 1976 Feb;73(2):620–624. doi: 10.1073/pnas.73.2.620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hunsmann G., Moennig V., Schäfer W. Properties of mouse leukemia viruses. IX. Active and passive immunization of mice against Friend leukemia with isolated viral GP71 glycoprotein and its corresponding antiserum. Virology. 1975 Jul;66(1):327–329. doi: 10.1016/0042-6822(75)90203-2. [DOI] [PubMed] [Google Scholar]
  21. KLEIN E., KLEIN G. ANTIGENIC PROPERTIES OF LYMPHOMAS INDUCED BY THE MOLONEY AGENT. J Natl Cancer Inst. 1964 Mar;32:547–568. [PubMed] [Google Scholar]
  22. Kelloff G. J., Peters R. L., Donahoe R. M., Ghazzouli I., Sass B., Nims R. M., Huebner R. J. An approach to C-type virus immunoprevention of spontaneously occurring tumors in laboratory mice. Cancer Res. 1976 Feb;36(2 Pt 2):622–630. [PubMed] [Google Scholar]
  23. Lamon E. W., Anderson B., Wigzell H., Fenyö E. M., Klein E. The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors. Int J Cancer. 1974 Jan 15;13(1):91–104. doi: 10.1002/ijc.2910130111. [DOI] [PubMed] [Google Scholar]
  24. Lavrin D. H., Herberman R. B., Nunn M., Soares N. In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice. J Natl Cancer Inst. 1973 Nov;51(5):1497–1508. doi: 10.1093/jnci/51.5.1497. [DOI] [PubMed] [Google Scholar]
  25. Mayyasi S. A., Moloney J. B. Induced resistance of mice to a lymphoid strain of leukemia virus (Moloney). Cancer. 1967 Jul;20(7):1124–1130. doi: 10.1002/1097-0142(196707)20:7<1124::aid-cncr2820200715>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  26. PASTERNAK G., GRAFFI A. INDUCTION OF RESISTANCE AGAINST ISOTRANSPLANTATION OF VIRUS-INDUCED MYELOID LEUKAEMIAS. Br J Cancer. 1963 Sep;17:532–539. doi: 10.1038/bjc.1963.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. PRECERUTTI A., LAW L. W. Isolation of a murine leukaemogenic virus P-LLV. Nature. 1963 May 25;198:801–803. doi: 10.1038/198801b0. [DOI] [PubMed] [Google Scholar]
  28. Pazmiño N. H., Yuhas J. M. Senescent loss of resistance to murine sarcoma virus (Moloney) in the mouse. Cancer Res. 1973 Nov;33(11):2668–2672. [PubMed] [Google Scholar]
  29. Perk K., Moloney J. B. Pathogenesis of a virus-induced rhabdomyosarcoma in mice. J Natl Cancer Inst. 1966 Nov;37(5):581–599. [PubMed] [Google Scholar]
  30. SACHS L. Transplantability of an x-ray-induced and a virus-induced leukemia in isologous mice inoculated with a leukemia virus. J Natl Cancer Inst. 1962 Oct;29:759–764. [PubMed] [Google Scholar]
  31. SLETTENMARK B., KLEIN E. Cytotoxic and neutralization tests with serum and lymph node cells of isologous mice with induced resistance against gross lymphomas. Cancer Res. 1962 Sep;22:947–954. [PubMed] [Google Scholar]
  32. Simons P. J., McCully D. J. Pathologic and virologic studies of tumors induced in mice by two strains of murine sarcoma virus. J Natl Cancer Inst. 1970 Jun;44(6):1289–1303. [PubMed] [Google Scholar]
  33. Turner W., Chirigos M. A. Enhancement of murine sarcoma virus (Moloney) infection and tumorigenesis in vivo by coinfection with Rauscher leukemia virus. Cancer Res. 1969 Nov;29(11):1956–1960. [PubMed] [Google Scholar]
  34. Tyndall R. L., Otten J. A., Teeter E., Bowles N. D. Inhibition of solid tumor formation by prior immunization with formalized neoplastic spleen extracts. Proc Soc Exp Biol Med. 1967 Jun;125(2):399–402. doi: 10.3181/00379727-125-32102. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES